A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
No long-term associations seen for depression symptoms and later binge drinking, lack of engagement in education and work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback